Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
PHASE1CompletedINTERVENTIONAL
Enrollment
45
Participants
Timeline
Start Date
April 30, 2000
Conditions
Pancreatic Cancer
Interventions
DRUG
motexafin gadolinium
RADIATION
radiation therapy
Trial Locations (1)
21287
Johns Hopkins Oncology Center, Baltimore
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER
NCT00003798 - Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter